U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 31 - August 6, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 31 - August 6, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 08/02/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: COURTNEY BUCHANAN; SUSAN MAYNE; JULIA TIERNEY; TRISTAN COLONIUS; CAITLIN BOON;
Non FDA Participant/Group: Alex Biella, Art Pike, Audrae Erickson, Justin Griner, Robert Cleveland (Reckitt); Stephen Cha (Health and Human Services);

Event Date: 08/02/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: FRANK YIANNAS; SUSAN MAYNE; JULIA TIERNEY; COURTNEY BUCHANAN; TRISTAN COLONIUS;
Non FDA Participant/Group: Dennis Lin, Kristy Carr (Bubs Australia);

Event Date: 08/02/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: TRISTAN COLONIUS; FRANK YIANNAS; JULIA TIERNEY; COURTNEY BUCHANAN;
Non FDA Participant/Group: Andy Kettlewell, Chuck Greener, Luke Rauch, Rina Shah, Rosalind Brewer, Tracey Brown (Walgreens);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 08/04/2022
Location: Virtual
Subject: Alliance for a Stronger FDA Webinar; Plans for Technology, Data, and Enterprise Modernization
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of Alliance for a Stronger FDA

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/01/2022
Location: Pittsburgh, PA
Subject: International Association for Food Protection Annual Meeting; Speaker: Regulatory Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, academia, and governmental food safety

Event Date: 08/05/2022
Location: Virtual
Subject: Infant Formula Data Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Brad LaRock (Datasembly Inc);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 08/03/2022
Location: Virtual
Subject: International Coalition of Medicines Regulatory Authorities (ICMRA) Executive Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: International Coalition of Medicines Regulatory Authorities (ICMRA) Committee members

Event Date: 08/04/2022
Location: Virtual
Subject: Duke-Margolis Webinar on Endpoint Considerations to Facilitate Drug Development for Niemann-Pick Type C (NPC); Opening Remarks: Key Themes and Future Directions
FDA Participant/Group: AUDREY THOMAS;
Non FDA Participant/Group: Attendees from industry, government, academia, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 08/03/2022
Location: Virtual
Subject: 2022 America's Blood Centers' MD Workshop and Summer Summit; Speaker: FDA Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the 2022 America's Blood Centers' MD Workshop and Summer Summit

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 08/01/2022
Location: Virtual
Subject: Patient Safety and Quality Improvement Program (PSQIP) Progress Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Laura Mauri, Geoff Martha, Yarmela Pavlovic, Noel Colon, Brian Barry, Jennifer Doyle, Gerardine Finn, Sean Salmon, Brett Wall, Bob White, Greg Smith, Malia Lowe, Chris Harrold, Olaf Hedrich, Rebecca Seidel (Medtronic)

Event Date: 08/04/2022
Location: Virtual
Subject: Evaluation of Medical Devices
FDA Participant/Group: COURTNEY LIAS; ANGELA CALMAN; NANCY COLLAZO BRAIER; WILLIAM MAISEL; JAMES LEE; KEISHA THOMAS; EDWARD MARGERRISON; ELIZABETH HILLEBRENNER; KATELYN BITTLEMAN; DOUGLAS KELLY;
Non FDA Participant/Group: Erin Sparnon, Jason Launders, Chris Lavanchy, Rinehart Stefanie, Joseph Welsh, Dheerendra Kommala (Emergency Care Research Institute)

Event Date: 08/04/2022
Location: Virutal
Subject: Dialysis Machine Distribution Hold
FDA Participant/Group: MICHAEL HOFFMANN; KATHLEEN WHITE; COURTNEY LIAS; JOYCE WHANG; DOUGLAS SILVERSTEIN; TAMMY BECKHAM; GLENN BELL; GEMA GONZALEZ; DOUGLAS KELLY;
Non FDA Participant/Group: Jeffrey Giullian, Kayla Amodeo, David Mahoney, Joelle Thornhill (DaVita)

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 08/02/2022
Location: Virtual
Subject: FDA’s Nutrition Priorities
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Darisuh Mozaffarian (Tufts University);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 
Back to Top